Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$309.3K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
1 of 3 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 51 business days late.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays.
The 13 most recent Form 4 transactions.
| Apr 7 | KNSA | Kiniksa Pharmaceuticals… | FTAX | 1,666 | $48.94 | $81.5K | -4.7% | Open the original filing on SEC.gov |
| Apr 7 | KNSA | Kiniksa Pharmaceuticals… | MEXER | 3,932 | $1.00 | $3.9K | +12.4% | Open the original filing on SEC.gov |
| Apr 1 | KNSA | Kiniksa Pharmaceuticals… | MEXER◆ | 2,644 | — | — | — | Open the original filing on SEC.gov |
| Apr 1 | KNSA | Kiniksa Pharmaceuticals… | MEXER◆ | 2,362 | — | — | — | Open the original filing on SEC.gov |
| Apr 1 | KNSA | Kiniksa Pharmaceuticals… | MEXER◆ | 2,558 | — | — | — | Open the original filing on SEC.gov |
| Apr 1 | KNSA | Kiniksa Pharmaceuticals… | AGRANT◆ | 7,300 | — | — | — | Open the original filing on SEC.gov |
| Apr 1 | KNSA | Kiniksa Pharmaceuticals… | AGRANT◆ | 3,650 | — | — | — | Open the original filing on SEC.gov |
| Apr 1 | KNSA | Kiniksa Pharmaceuticals… | AGRANT◆ | 14,600 | — | — | — | Open the original filing on SEC.gov |
| Apr 1 | KNSA | Kiniksa Pharmaceuticals… | FTAX | 3,205 | $48.13 | $154.3K | -9.2% | Open the original filing on SEC.gov |
| Apr 1 | KNSA | Kiniksa Pharmaceuticals… | MEXER | 7,564 | — | — | +27.6% | Open the original filing on SEC.gov |
| Jan 15 | KNSA | Kiniksa Pharmaceuticals… | AGRANT | 372 | $24.16 | $9K | +1.4% | Open the original filing on SEC.gov |